Eye Laser Company IPO Contends With Microkeratome Competition, Debt
This article was originally published in The Gray Sheet
Executive Summary
IntraLase Corp. will target its IntraLase FS precision laser to the 1,400 LASIK centers in the U.S. and 4,100 abroad that perform at least 50 procedures per month, the firm says in its IPO prospectus, filed with the Securities & Exchange Commission May 28
You may also be interested in...
IntraLase Eye Lasers Continue To Take Share From Microkeratome Blades
IntraLase estimates that its FS precision laser will be used in 25% of U.S. corneal flap procedures by next year, up from 16% in the fourth quarter of 2004
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.